|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-3.60/-3.61
|
企业价值
10.63M
|
资产负债 |
每股账面净值
1.79
|
现金流量 |
现金流量率
--
|
损益表 |
收益
22.05K
|
每股收益
0.00
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/08 16:39 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia. |